Adding Talazoparib to Enzalutamide Prolongs Imaging-Based PFS in Metastatic Androgen Pathway Modulation-Sensitive Prostate Cancer with Alterations in HRR Genes By Ogkologos - June 15, 2026 87 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TALAPRO-3 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism MOST POPULAR Aspirin Being Investigated as Possible Treatment for Triple Negative Breast Cancer August 21, 2021 Encouraging Single-Agent Antitumour Activity of Divarasib Across KRAS G12C-positive Tumours September 5, 2023 Kid Friendly Meals October 2, 2020 Empoderar a las personas con cáncer: preguntas y respuestas con la... June 8, 2021 Load more HOT NEWS 2022 ASCO Annual Meeting: Using Biomarker Testing to Avoid Radiation Therapy in... Washington Farmers Harvest Crops For Neighbor With Stage Four Cancer Targeting Inflammation Emerges as a Strategy for Treating Cancer 20.° Aniversario de Cancer.Net: Celebramos Nuestra Misión de Brindar Información Confiable...
